MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
50.84
-2.57 (-4.81%)
Nov 20, 2026, 12:24 PM EST - Market open
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $2.52 billion as of November 20, 2026. It is the 5,383rd most valuable company in the world and the 1,568th biggest in the United States. Its market cap has increased by 105.27% in one year.
Market Cap
2.52B
Enterprise Value
2.05B
1-Year Change
105.27%
Global Rank
Country Rank
#1,568 United States
Category
ChartMarket Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $2.52B, an increase of 395.34%. That is a compound annual growth rate of 107.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.52B | 78.26% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 (IPO) | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 3.03B |
| Dyne Therapeutics | 3.00B |
| Telix Pharmaceuticals | 3.00B |
| Vericel | 2.97B |
| ADMA Biologics | 2.96B |
| Denali Therapeutics | 2.92B |
| Celcuity | 2.77B |
| Xencor | 2.55B |